PUMA BIOTECHNOLOGY, INC. 8-K

What Happened
Puma Biotechnology, Inc. (PBYI) filed a Form 8‑K on February 26, 2026 to announce its financial results for the fourth quarter and fiscal year ended December 31, 2025. The company issued a press release dated February 26, 2026 reporting those results; the press release was furnished as Exhibit 99.1 to the 8‑K and is incorporated by reference.

Key Details

• Filing date: February 26, 2026 (Form 8‑K, Item 2.02 — Results of Operations and Financial Condition).
• Reporting period: fourth quarter and fiscal year ended December 31, 2025.
• Press release dated February 26, 2026 furnished as Exhibit 99.1.
• Interactive XBRL cover page data was included (Exhibit 104).

Why It Matters
This 8‑K provides the company’s official quarterly and full‑year results, which are the primary source for updated earnings, revenue, and other performance metrics for FY2025. Retail investors should review the furnished press release (Exhibit 99.1) for the specific financial figures, any management commentary, and indications about trends or outlook. Because this covers year‑end results, investors should also watch for the company’s subsequent periodic filings (including the annual report on Form 10‑K) for audited financials and more detailed disclosures.